Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-020477)

Filing Details

Accession Number:: 0001209191-23-020477
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-22 16:01:41
Reporting Period:: 2023-03-20

Accepted Time:: 2023-03-22 16:01:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1566044	Vyne Therapeutics Inc.	VYNE	Pharmaceutical Preparations (2834)	453757789

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1727809	Mutya Harsch	C/O Vyne Therapeutics Inc. 685 Route 202/206, Suite 301A Bridgewater NJ 08807	Chief Legal Officer And Gc	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-20	10,000	$2.50	22,721	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.